Clinical application of amplicon-based next-generation sequencing in cancer

Cancer Genetics

Volumn 206, Issue 12, 2013, Pages 413-419

  Chang, Fengqi ^a   Li, Marilyn M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Amplicon based targeted sequencing; Cancer; Next generation sequencing

Indexed keywords

AMPLICON-BASED TARGETED SEQUENCING; CANCER; NEXT-GENERATION SEQUENCING;

GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 84893838300     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2013.10.003     Document Type: Review

References (45)

1. Rusk N., Kiermer V. Primer: sequencing: the next generation. Nat Methods 2008, 5:15.
2. Shyr D., Liu Q. Next generation sequencing in cancer research and clinical application. Biol Proced Online 2012, 15:4.
3. D'Antonio M., Pendino V., Sinha S., et al. Network of Cancer Genes (NCG 3.0): integration and analysis of genetic and network properties of cancer genes. Nucleic Acids Res 2012, 40:D978-D983.
4. Abdel-Wahab O. Molecular genetics of acute myeloid leukemia: clinical implications and opportunities for integrating genomics into clinical practice. Hematology 2012, 17:S39-S42.
5. Druker B.J., Talpaz M., Resta D.J., et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. NEngl J Med 2001, 344:1031-1037.
6. Mitsudomi T., Morita S., Yatabe Y., et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised Phase 3 trial. Lancet Oncol 2009, 11:121-128.
7. Mok T.S., Wu Y.L., Thongprasert S., et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinama. NEngl J Med 2009, 361:947-957.
8. Rosell R., Moran T., Queralt C., et al. Screening for epidermal growth factor receptor mutations in lung cancer. NEngl J Med 2009, 361:958-967.
9. Peters S., Taron M., Bubendorf L., et al. Treatment and detection of ALK-rearranged NSCLC. Lung Cancer 2013, 81:145-154.
10. Schweiger M.R., Kerick M., Timmermann B., et al. The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations. Cancer Metastasis Rev 2011, 30:199-210.
11. Klee E.W., Hoppman-Chaney N.L., Ferber M.J. Expanding DNA diagnostic panel testing: is more better?. Expert Rev Mol Diagn 2011, 11:703-709.
12. Mardis E.R. The impact of next-generation sequencing technology on genetics. Trends Genet 2008, 24:133-141.
13. Shendure J., Ji H. Next-generation DNA sequencing. Nat Biotechnol 2008, 26:1135-1145.
14. Metzker M.L. Sequencing technologies - the next generation. Nat Rev Genet 2010, 11:31-46.
15. Liu L., Li Y., Li S., et al. Comparison of next-generation sequencing systems. JBiomed Biotechnol 2012, 2012:251364.
16. Zhou X., Ren L., Meng Q., et al. The next-generation sequencing technology and application. Protein Cell 2010, 1:520-536.
17. Voelkerding K.V., Dames S.A., Durtschi J.D. Next-generation sequencing: from basic research to diagnostics. Clin Chem 2009, 55:641-658.
18. Rothberg J.M., Leamon J.H. The development and impact of 454 sequencing. Nat Biotechnol 2008, 26:1117-1124.
19. Margulies M., Egholm M., Altman W.E., et al. Genome sequencing in microfabricated high density picolitre reactors. Nature 2005, 437:376-380.
20. Rothberg J.M., Hinz W., Rearick T.M., et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature 2011, 475:348-352.
21. Tewhey R., Warner J.B., Nakano M., et al. Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nat Biotechnol 2009, 11:1025-1031.
22. ™ system for simplified amplicon library preparation. Tissue Antigens 2013, 81:141-149.
23. Langmead B., Salzberg S.L. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012, 9:357-359.
24. Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25:1754-1760.
25. Li H., Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010, 26:589-595.
26. Li R., Yu C., Li Y., et al. SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics 2009, 25:1966-1967.
27. Li H., Ruan J., Durbin R. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res 2008, 18:1851-1858.
28. Trapnell C., Pachter L., Salzberg S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009, 25:1105-1111.
29. Li H., Handsaker B., Wysoker A., et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009, 25:2078-2079.
30. Dalca A.V., Rumble S.M., Levy S., et al. VARiD: a variation detection framework for color-space and letter-space platforms. Bioinformatics 2010, 26:i343-i349.
31. Koboldt D.C., Zhang Q., Larson D.E., et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 2012, 22:568-576.
32. Au K.F., Jiang H., Lin L., et al. Detection of splice junctions from paired-end RNA-seq data by SpliceMap. Nucleic Acids Res 2010, 38:4570-4578.
33. Jia W., Qiu K., He M., et al. SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data. Genome Biol 2013, 14:R12.
34. Piazza R., Pirola A., Spinelli R., et al. FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery. Nucleic Acids Res 2012, 40:e123.
35. Fiume M., Williams V., Brook A., et al. Savant: genome browser for high-throughput sequencing data. Bioinformatics 2010, 26:1938-1944.
36. Adzhubei I.A., Schmidt S., Peshkin L., et al. Amethod and server for predicting damaging missense mutations. Nat Methods 2010, 7:248-249.
37. Kumar P., Henikoff S., Ng P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009, 4:1073-1081.
38. Wong W.C., Kim D., Carter H., et al. CHASM and SNVBox: toolkit for detecting biologically important single nucleotide mutations in cancer. Bioinformatics 2011, 27:2147-2148.
39. Wang K., Li M., Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010, 38:e164.
40. Wheeler D.L., Barrett T., Benson D.A., et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2007, 35:D5-D12.
41. Cooper D.N., Stenson P.D., Chuzhanova N.A. The Human Gene Mutation Database (HGMD) and its exploitation in the study of mutational mechanisms. Curr Protoc Bioinformatics 2006, Chapter 1:Unit 1.13.
42. Cook-Deegan R., Conley J.M., Evans J.P., et al. The next controversy in genetic testing: clinical data as trade secrets?. Eur J Hum Genet 2013, 21:585-588.
43. Soden S.E., Farrow E.G., Saunders C.J., et al. Genomic medicine: evolving science, evolving ethics. Per Med 2012, 9:523-528.
44. Korf B.R., Rehm H.L. New approaches to molecular diagnosis. JAMA 2013, 309:1511-1521.
45. Fialho A.M., Chakrabarty A.M. Patent controversies and court cases: cancer diagnosis, therapy and prevention. Cancer Biol Ther 2012, 13:1229-1234.